Beta Drugs Limited (BETA) Share Price & AI Investment Analysis

Beta Drugs Limited develops, manufactures, and sells anti-cancer bulk drugs and finished dosages in India. The company offers cosmeceutical and oncology products. It also manufactures active pharmaceutical ingredients (API) and pharmaceutical formulation intermediates (PFI). The company exports its products. Beta Drugs Limited was founded in 1985 and is based in Panchkula, India. Track Beta Drugs Limited's live NSE:BETA share price ₹2,105.00 (+1.47%), market cap ₹₹21B, P/E 47.6. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for BETA — real-time NSE India stock intelligence.